http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112294842-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5850d4876790409ee555724f9791c79d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00511
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26
filingDate 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4589821534e900682df3714b9ce6e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50436f57fe8185abf63258f424a38e2f
publicationDate 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112294842-A
titleOfInvention A holmium laser lithotripsy protective solution to protect kidney tissue
abstract The invention provides a holmium laser lithotripsy protection solution for protecting kidney tissue, belonging to the technical field of in vivo laser lithotripsy protection. The holmium laser lithotripsy protection solution includes iron sucrose injection, chitosan, sodium chloride, oleanolic acid and PBS buffer, wherein the oleanolic acid accounts for 0.2-0.15% by mass and volume, and the chitosan According to the mass volume ratio, it accounts for 0.05-0.3%, the sodium chloride accounts for 0.9% according to the mass volume ratio, and the iron sucrose injection accounts for 1-5% according to the volume ratio. The invention is non-toxic and harmless, has minimal side effects on the human body, is not suitable for use by only a small number of special groups, and has a wide range of use. The preparation method of the invention is simple, the proportioning is easy to grasp, and after use, the kidney damage of patients with renal calculus can be greatly reduced. Has strong practicality.
priorityDate 2020-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-211271125-U
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2796100-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002119116-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51892422
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552417
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423357075
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16217673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449789534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23961
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10494
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234

Total number of triples: 45.